http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102143241-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2013-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102143241-B1 |
titleOfInvention | PRDM14 and FAM19A4, molecular diagnostic markers for HPV-induced invasive cancers and their high-grade precursor lesions |
abstract | The present invention relates to a method for detecting HPV-induced high grade precancerous lesions and HPV-induced invasive cancer, the method comprising the detection of ultra-high methylation in the PRDM14 and/or FAM19A4 gene in cells, whereby such ultra-high methylation Represents the presence of HPV-induced progenitor lesions and HPV-induced invasive cancer with invasive potential. Furthermore, the present invention includes test kits for the use of PRDM14 and/or FAM19A4 genes in this method and detection of PRDM14 and/or FAM19A4 methylation. |
priorityDate | 2012-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.